Full Paper
2
4
4
C5H3), 3.81 (br, 2H, NH2), 3.85 (d, JH,H = 15.9 Hz, 1H, CH2), 3.93 (d,
131.1 (d, JC,P = 3.0 Hz, 1C, C6H5), 131.2 (d, JC,P = 2.9 Hz, 1C, C6H5),
131.4 (d, 4JC,P = 2.8 Hz, 1C, C6H5), 131.7 (d, JC,P = 10.7 Hz, 2C, C6H5),
131.9 (d, JC,P = 10.6 Hz, 2C, C6H5), 132.0 (d, JC,P = 10.8 Hz, 4C, C6H5),
2JH,H = 15.9 Hz, 1H, CH2), 4.25 (dd, J = 4.1, 2.5 Hz, 1H, C5H3), 4.33 (s,
5H, C5H5), 4.45 (dd, J = 3.8, 1.9 Hz, 1H, C5H3), 6.43 (dd, 3JH,H = 7.9 Hz,
3
4
1
1
4JH,H = 1.1 Hz, 1H, C6H4), 6.57 (td, JH,H = 7.4 Hz, JH,H = 1.2 Hz, 1H,
133.2 (d, JC,P = 85.9 Hz, 1C, qC6H5), 133.7 (d, JC,P = 85.9 Hz, 1C,
3
4
C6H4), 6.88 (td, JH,H = 7.7 Hz, JH,H = 1.5 Hz, 1H, C6H4), 6.97 (dd,
qC6H5), 134.2 (d, 1JC,P = 86.7 Hz, 1C, qC6H5), 134.6 (d, 1JC,P = 86.8 Hz,
3JH,H = 7.6 Hz, JH,H = 1.4 Hz, 1H, C6H4), 7.22–7.26 (m, 2H, C6H5),
1C, C6H5), 145.3 (1C, CC6H4–NH) ppm. 31P{1H} NMR (CDCl3, δ): 41.7,
4
q
7.34–7.37 (m, 1H, C6H5), 7.45–7.53 (m, 5H, C6H5), 7.78–7.83 (m, 2H,
42.2 ppm.
C6H5) ppm. 13C{1H} NMR (CDCl3, δ): 28.9 (1C, CH2), 68.6 (d, JC,P
=
Reaction of (Sp)-1 with N,N-dimethylaniline
10.5 Hz, 1C, C5H3), 70.8 (s, 5C, C5H5), 73.67 (d, JC,P = 9.8 Hz, 1C,
C5H3), 73.73 (d, 1JC,P = 95.5 Hz, 1C, CC5H3–P), 74.28 (d, JC,P = 13.0 Hz,
Compound (Sp)-1a (600 mg, 1.40 mmol), pTsOH (1.58 g, 8.4 mmol)
and aniline (0.48 mL, 4.2 mmol) were reacted according to GP1.
Purification was realized by column chromatography (silica,
4 × 14 cm) using a 5:1 hexane/ethyl acetate mixture (v/v) as the
eluent. At first o-(Sp)-5 could be eluted, followed by (Sp,Sp)-12
(126 mg, 0.438 mmol, 31 % based on (Sp)-1a) containing traces
(< 5 %) of p-(Sp)-5 in a non-separable mixture.
2
1C, C5H3), 92.0 (d, JC,P = 12.6 Hz, 1C, CC5H3–C), 115.7 (1C, C6H4),
118.0 (1C, C6H4), 124.9 (1C, CC6H4–C), 126.9 (1C, C6H4), 127.97 (d,
JC,P = 12.5 Hz, 2C, C6H5), 128.01 (d, JC,P = 12.4 Hz, 2C, C6H5), 130.2
4
4
(1C, C6H4), 131.1 (d, JC,P = 2.9 Hz, 1C, 4-C6H5), 131.3 (d, JC,P
=
=
2.9 Hz, 1C, 4-C6H5), 131.8 (d, JC,P = 10.6 Hz, 2C, C6H5), 132.0 (d, JC,P
10.9 Hz, 2C, C6H5), 133.2 (d, JC,P = 86.2 Hz, 1C, qC6H5), 133.8 (d,
1JC,P = 86.4 Hz, 1C, qC6H5), 144.3 (1C, C–NH2) ppm. 31P{1H} NMR
(CDCl3, δ): 42.2 ppm.
1
(Sp)-2-((2-(N,N-Dimethylamino)phenyl)methyl)-1-(thiodiphenyl-
phosphino)-ferrocene o-(Sp)-5
(Sp)-2-((4-Aminophenyl)methyl)-1-(thiodiphenylphosphino)-
ferrocene p-(Sp)-3
Yield: 93 mg (0.18 mmol, 13 % based on (Sp)-1a). Orange solid. Anal.
Calcd for C31H30FeNPS·1/6 C6H14 (535.46·1/6 86.18 g/mol): C, 69.90;
H, 5.93; N, 2.55; found C, 69.82; H, 6.22; N, 2.33. Mp: 167–170 °C. H
NMR (CDCl3, δ): 2.56 (s, 6H, CH3), 3.73 (dd, J = 3.7, 2.2 Hz, 1H, C5H3),
4.14 (s, 2H, CH2), 4.18 (dd, J = 4.1, 2.4 Hz, 1H, C5H3), 4.24–4.25 (m,
1
Compound p-(Sp)-3 was obtained in a mixture with its ortho-deriva-
tive. NMR-Yield: 139 mg (0.247 mmol, 20 % based on (Sp)-1a).
Orange solid.
3
4
1H, C5H3), 4.34 (s, 5H, C5H5), 6.76 (td, JH,H = 7.4 Hz, JH,H = 1.3 Hz,
1H NMR (CDCl3, δ): 3.47 (br, 2H, NH2), 3.65 (dd, J = 3.7, 2.2 Hz, 1H,
C5H3), 3.83 (d, 2JH,H = 15.2 Hz, 1H, CH2), 4.06 (d, 2JH,H = 15.2 Hz, 1H,
CH2), 4.21 (dd, J = 4.0, 2.4 Hz, 1H, C5H3), 4.32 (s, 5H, C5H5), 4.36–
3
4
1H, C6H4), 6.99 (dd, JH,H = 7.6 Hz, JH,H = 1.4 Hz, 1H, C6H4), 7.01
3
4
3
(dd, JH,H = 8.0 Hz, JH,H = 1.2 Hz, 1H, C6H4), 7.07 (td, JH,H = 8.0 Hz,
4JH,H = 1.5 Hz, 1H, C6H4), 7.30–7.34 (m, 2H, C6H5), 7.39–7.42 (m, 1H,
C6H5), 7.44–7.52 (m, 3H, C6H5), 7.63–7.67 (m, 2H, C6H5), 7.82–7.87
(m, 2H, C6H5) ppm. 13C{1H} NMR (CDCl3, δ): 29.7 (1C, CH2), 45.0 (2C,
3
3
4.37 (m, 1H, C5H3), 6.36 (d, JH,H = 8.3 Hz, 2H, C6H4), 6.83 (d, JH,H
=
8.2 Hz, 2H, C6H4), 7.22–7.25 (m, 2H, C6H5), 7.35–7.39 (m, 1H, C6H5),
7.42–7.51 (m, 5H, C6H5), 7.77–7.81 (m, 2H, C6H5) ppm. 13C{1H} NMR
(CDCl3, δ): 33.1 (1C, CH2), 68.5 (d, JC,P = 10.6 Hz, 1C, C5H3), 70.7 (5C,
CH3), 68.2 (d, JC,P = 10.5 Hz, 1C, C5H3), 70.8 (5C, C5H5), 73.9 (d, JC,P
=
1
13.1 Hz, 1C, C5H3), 73.8 (d, JC,P = 95.6 Hz, 1C, CC5H3–P), 74.1 (d,
1
2
C5H5), 73.5 (d, JC,P = 9.8 Hz, 1C, C5H3), 73.4 (d, JC,P = 95.5 Hz, 1C,
JC,P = 9.9 Hz, 1C, C5H3), 93.4 (d, JC,P = 12.5 Hz, 1C, CC5H3–C), 119.2
2
CC5H3–P), 74.3 (d, JC,P = 13.0 Hz, 1C, C5H3), 93.5 (d, JC,P = 12.5 Hz,
(1C, C6H4), 122.8 (1C, C6H4), 126.6 (1C, C6H4), 127.9 (d, JC,P = 12.4 Hz,
2C, C6H5), 128.0 (d, JC,P = 12.5 Hz, 2C, C6H5), 130.6 (1C, C6H4), 130.9
1C, CC5H3–C), 114.7 (2C, C6H4), 127.91 (d, JC,P = 12.3 Hz, 2C, C6H5),
127.93 (d, 1JC,P = 12.5 Hz, 2C, C6H5), 129.8 (2C, C6H4), 130.6 (d, 4JC,P
2.9 Hz, 1C, 4-C6H5), 130.7 (1C, CC6H4–CH2), 131.1 (d, JC,P = 2.9 Hz,
=
4
4
(d, JC,P = 2.9 Hz, 1C, 4-C6H5), 131.0 (d, JC,P = 3.0 Hz, 1C, 4-C6H5),
131.9 (d, JC,P = 10.2 Hz, 2C, C6H5), 132.0 (d, JC,P = 10.0 Hz, 2C, C6H5),
133.8 (d, 1JC,P = 85.9 Hz, 1C, 1-C6H5), 134.1 (d, 1JC,P = 86.2 Hz, 1C, 1-
C6H5), 135.4 (1C, CC6H4–C), 152.6 (1C, C–N) ppm. 31P{1H} NMR (CDCl3,
4
1C, 4-C6H5), 131.9 (d, JC,P = 10.6 Hz, 2C, C6H5), 132.0 (d, JC,P
=
1
10.8 Hz, 2C, C6H5), 133.7 (d, JC,P = 85.9 Hz, 1C, qC6H5), 134.2 (d,
1JC,P = 86.7 Hz, 1C, qC6H5), 144.0 (1C, qC–NH2) ppm. 31P{1H} NMR
(CDCl3, δ): 42.1 ppm.
δ): 41.9 ppm. IR data (KBr, ν = ): 3091, 3068, 2924, 2855, 1591, 1461,
˜
1309, 1145, 1105, 1034, 945, 824, 765, 747, 692, 660, 545,
506 cm–1. HRMS (ESI-TOF, m/z): calcd. for C31H30FeNPS 536.1259,
found 536.1302 [M]+.
(Sp,Sp)-N,4-Bis((2-(thiodiphenylphosphino)ferrocene-1-yl)meth-
yl)aniline (Sp,Sp)-4
Crystal Data for o-(Sp)-5: C31H30FeNPS, M = 535.44 g mol–1, mono-
clinic, P21, λ = 1.54184 Å, a = 9.9736(12) Å, b = 12.5762(14) Å, c =
Yield: 20 mg (0.022 mmol, 2 % based on (Sp)-1a). Orange oil. 1H
NMR (CDCl3, δ): 3.62 (dd, J = 3.7, 2.3 Hz, 1H, C5H3), 3.70 (dd, J = 3.7,
2.3 Hz, 1H, C5H3), 3.78 (d, 2JH,H = 15.2 Hz, 1H, CH2), 3.86 (br, 1H, NH),
11.1041(12) Å, ꢀ = 107.584(13) °, V = 1327.7(3) Å3, Z = 2, ρcalcd
=
1.339 Mg m–3, μ = 6.000 mm–1, T = 120 K, θ range 4.177–64.490°,
4958 reflections collected, 3096 independent reflections (Rint
2
2
3.95 (d, JH,H = 15.2 Hz, 1H, CH2), 4.10 (d, JH,H = 14.7 Hz, 1H, CH2),
4.19 (dd, J = 4.1, 2.5 Hz, 1H, C5H3), 4.26 (dd, J = 4.0, 2.4 Hz, 1H,
C5H3), 4.30 (s, 5H, C5H5), 4.31 (s, 5H, C5H5), 4.34 (dd, J = 3.7, 1.8 Hz,
1H, C5H3), 4.58 (dd, J = 3.8, 1.7 Hz, 1H, C5H3), 4.63 (d, 2JH,H = 14.7 Hz,
=
0.0641), R1 = 0.0548, wR2 = 0.1211 [I > 2σ(I)], absolute structure pa-
rameter[38] 0.006(9).
3
3
1H, CH2), 5.91 (d, JH,H = 8.5 Hz, 2H, C6H4), 6.67 (d, JH,H = 8.5 Hz,
2H, C6H4), 7.16–7.20 (m, 2H, C6H5), 7.24–7.27 (m, 2H, C6H5), 7.28–
7.32 (m, 1H, C6H5), 7.38–7.54 (m, 11H, C6H5), 7.76–7.82 (m, 2H, C6H5)
ppm. 13C{1H} NMR (CDCl3, δ): 33.1 (1C, CH2), 41.6 (1C, CH2), 68.4 (d,
JC,P = 10.4 Hz, 1C, C5H3), 68.7 (d, JC,P = 10.3 Hz, 1C, C5H3), 70.6 (5C,
Synthesis of 2-((4-(diphenylamino)phenyl)methyl)-1-(thiodi-
phenyl-phosphino)-ferrocene p-(Sp)-7
Compound (Sp)-1a (600 mg, 1.40 mmol), pTsOH (1.58 g, 8.4 mmol)
and triphenylamine (1.72 g, 7.0 mmol) were reacted according to
GP1. Purification was realized by column chromatography (silica,
4 × 14 cm) using a 5:1 hexane/ethyl acetate mixture (v/v) as the
eluent, which gave o-(Sp)-5 followed by (Sp,Sp)-12 (126 mg,
0.438 mmol, 31 % based on (Sp)-1a) always containing traces
(< 5 %) of p-(Sp)-5 in a non-separable mixture. Removal of all vola-
tiles in vacuo gave (Sp)-6 as orange solid.
1
C5H5), 70.7 (5C, C5H5), 73.29 (d, JC,P = 95.6 Hz, 1C, CC5H3–P), 73.5
(d, JC,P = 9.9 Hz, 1C, C5H3), 73.9 (d, 1JC,P = 95.0 Hz, 1C, CC5H3–P), 74.2
(d, JC,P = 12.9 Hz, 1C, C5H3), 74.50 (d, JC,P = 9.6 Hz, 1C, C5H3), 74.5
2
(d, JC,P = 12.6 Hz, 1C, C5H3), 91.0 (d, JC,P = 12.0 Hz, 1C, CC5H3–C),
94.4 (d, 2JC,P = 12.5 Hz, 1C, CC5H3–C), 112.4 (2C, C6H4), 127.9 (d, JC,P
=
12.3 Hz, 2C, C6H5), 127.97 (d, JC,P = 12.4 Hz, 2C, C6H5), 128.04 (d,
JC,P = 12.4 Hz, 2C, C6H5), 128.4 (d, JC,P = 12.5 Hz, 2C, C6H5), 128.9 Yield: 357 mg (0.54 mmol, 39 % based on (Sp)-1a). Anal. Calcd for
4
(1C, CC6H4–C), 129.4 (2C, C6H4), 130.9 (d, JC,P = 2.9 Hz, 1C, C6H5),
C41H34FeNPS ·[1]/2 EtOAc (659.60 ·1/2 88.11 g/mol): C, 73.40; H, 5.44;
Eur. J. Inorg. Chem. 2019, 973–987
982
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim